RankingsPricing
  1. US-listed companies
  2. CATALYST PHARMACEUTICALS, INC.
  3. Financials
  4. Return on equity (%)

CATALYST PHARMACEUTICALS, INC.【CPRX】

Market cap
$2.8B
P/E ratio
SummaryFinancials
Period EndReturn on equity (%) (Million USD)YoY (%)
Dec 31, 202429.4+41.59%
Dec 31, 202320.8-36.66%
Dec 31, 202232.8+56.15%
Dec 31, 202121-64.01%
Dec 31, 202058.3+26.57%
Dec 31, 201946.1-189.23%
Dec 31, 2018-51.6+68.58%
Dec 31, 2017-30.6-19.70%
Dec 31, 2016-38.1-14.53%
Dec 31, 2015-44.6-18.55%
Dec 31, 2014-54.8-18.86%
Dec 31, 2013-67.5+52.20%
Dec 31, 2012-44.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)